Buscar por Autor Fries, Louis
Mostrando resultados 1 a 2 de 2
| Fecha de publicación | Título | Autor(es) |
| 2020-09-02 | Phase 1–2 Trial of a SARS-CoV-2 Recombinant Spike Protein Nanoparticle Vaccine | Keech, C.; Albert, G.; Cho, I.; Robertson, A.; Reed, P.; Neal, S.; Plested, J. S.; Zhu, M.; Cloney-Clark, S.; Zhou, H.; Smith, G.; Patel, Nita; Frieman, Matthew B.; Haupt, R. E.; Logue, James; McGrath, M.; Weston, S.; Piedra, Pedro A.; Desai, C.; Callahan, K.; Lewis, M.; Price-Abbott, P.; Formica, N.; Shinde, V.; Fries, Louis; Lickliter, J. D.; Griffin, P.; Wilkinson, B.; Glenn, Gregory |
| 2021-01-14 | SARS-CoV-2 spike glycoprotein vaccine candidate NVX-CoV2373 immunogenicity in baboons and protection in mice | Tian, Jing-Hui; Patel, Nita; Haupt, Robert; Zhou, Haixia; Weston, Stuart; Hammond, Holly; Logue, James; Portnoff, Alyse D.; Norton, James; Guebre-Xabier, Mimi; Zhou, Bin; Jacobson, Kelsey; Maciejewski, Sonia; Khatoon, Rafia; Wisniewska, Malgorzata; Moffitt, Will; Kluepfel-Stahl, Stefanie; Ekechukwu, Betty; Papin, James; Boddapati, Sarathi; Wong, C. Jason; Piedra, Pedro A.; Frieman, Matthew B.; Massare, Michael J.; Fries, Louis; Lövgren Bengtsson, Karin; Stertman, Linda; Ellingsworth, Larry; Glenn, Gregory; Smith, Gale |
